Akari Therapeutics (AKTX) Share-based Compensation Growth (3y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -34.72% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 4.80% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 10.78% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 2.55% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 20.65% |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.80% |
| Jun 30, 2025 | 80.21% |
| Mar 31, 2025 | 117.36% |
| Dec 31, 2024 | 25.99% |
| Sep 30, 2024 | -98.99% |
| Jun 30, 2024 | 75.66% |
| Mar 31, 2024 | 51.64% |
| Dec 31, 2023 | 98.58% |
| Sep 30, 2023 | -98.92% |
| Jun 30, 2023 | 25.99% |
| Mar 31, 2023 | -98.62% |
| Jun 30, 2022 | -33.06% |
| Mar 31, 2022 | -36.96% |
| Dec 31, 2021 | -8,188.14% |
| Sep 30, 2021 | 8,279.94% |
| Jun 30, 2021 | -38.44% |
| Mar 31, 2021 | -43.71% |
| Dec 31, 2020 | -7,752.15% |
| Sep 30, 2020 | 7,883.70% |
| Jun 30, 2020 | -4,858.20% |
| Mar 31, 2020 | 4,675.02% |
| Dec 31, 2019 | -56.51% |
| Sep 30, 2019 | -48.79% |
| Jun 30, 2019 | -20.18% |
| Mar 31, 2019 | -21.55% |
| Dec 31, 2018 | 24.98% |
| Sep 30, 2018 | -21.23% |
| Jun 30, 2017 | 74.19% |
| Mar 31, 2017 | 67.91% |
| Dec 31, 2015 | -18.43% |